Internal Medicine, Pulmonary Disease · Columbia, SC
NPI
1538347661
Since 2008
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1333 Taylor St, Suite 6b
Columbia, SC, 29201
Phone (803) 251-3093
Groups this clinician bills Medicare through
Medicare paid, 2024
$213K
2,409 services
Medicare patients, 2024
1,425
Average age 73
Drug cost, 2024
$3.3M
2,224 prescriptions
Company payments, 2025
$421K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard K Bogan was code 99214 (office e&m - established), 2,077 times for 1,325 patients. In total Richard K Bogan billed 2,409 services in 11 codes, and Medicare paid $213K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,077 | 1,325 | $84.35 | $175K |
| 99204 Office E&M - New | Office | 110 | 110 | $103.53 | $11K |
| 95810 Sleep Study | Office | 64 | 62 | $154.80 | $9,907 |
| 95811 Sleep Study | Office | 47 | 47 | $142.27 | $6,687 |
| 95800 Sleep Study | Office | 28 | 27 | $62.95 | $1,762 |
| 99215 Office E&M - Established | Office | 27 | 23 | $122.17 | $3,299 |
| 95806 Sleep Study | Office | 25 | 25 | $32.77 | $819 |
| 99205 Office E&M - New | Office | 22 | 22 | $138.81 | $3,054 |
By year: 2022 $200K for 2,027 services; 2023 $264K for 2,565 services; 2024 $213K for 2,409 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard K Bogan prescribed most often to Medicare patients was Gabapentin, with 330 prescriptions and refills. In total Richard K Bogan wrote 2,224 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 330 | 539 | 83 | $3,739 |
| Clonazepam Generic | 170 | 202 | 40 | $755 |
| Zolpidem Tartrate Generic | 131 | 155 | 30 | $708 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 114 | 114 | 32 | $3,535 |
| Modafinil Generic | 113 | 136 | 33 | $16K |
| Eszopiclone Generic | 100 | 110 | 18 | $826 |
| Belsomra Suvorexant | 79 | 83 | 31 | $36K |
| Trazodone Hcl Generic | 76 | 136 | 17 | $1,871 |
| Zaleplon Generic | 69 | 79 | 23 | $1,703 |
| Sunosi Solriamfetol Hcl | 64 | 66 | 14 | $54K |
| Xywav Sodium,calcium,mag,pot Oxybate | 61 | 61 | Under 11 | $997K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 59 | 113 | 13 | $1,025 |
| Armodafinil Generic | 57 | 73 | 15 | $3,219 |
| Temazepam Generic | 51 | 55 | Under 11 | $1,546 |
| Pregabalin Generic | 51 | 65 | 11 | $395 |
Brand drugs: 424 claims; generic drugs: 1,800 claims; opioid claims: 99.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard K Bogan $421K ($232K in general payments such as food, travel and fees and $189K for research) from 17 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $228K.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 29 | $228K |
| Jazz Pharmaceuticals Inc. JAZZ | 103 | $121K |
| Axsome Therapeutics, Inc. AXSM | 51 | $53K |
| Alkermes, Inc. ALKS | 7 | $14K |
| Harmony Biosciences LLC HRMY | 10 | $4,227 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $103 |
| Lilly USA, LLC LLY | 2 | $37.24 |
| Inspire Medical Systems, Inc. INSP | 2 | $37.16 |
| Fisher & Paykel Healthcare Inc FPH.NZ | 1 | $36.13 |
| Genzyme Corporation SNY | 1 | $24.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.